Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populations

Human Molecular Genetics

Volumn 23, Issue 6, 2014, Pages 1656-1668

  Kim Howard, Xana ^a   Sun, Celi ^a   Molineros, Julio E ^a   Maiti, Amit K ^a   Chandru, Hema ^a   Adler, Adam ^a   Wiley, Graham B ^a   Kaufman, Kenneth M ^b   Kottyan, Leah ^b   Guthridge, Joel M ^a   Rasmussen, Astrid ^a   Kelly, Jennifer ^a   Sánchez, Elena ^a   Raj, Prithvi ^c   Li, Quan Zhen ^c   Bang, So Young ^d   Lee, Hye Soon ^d   Kim, Tae Hwan ^d   Kang, Young Mo ^e   Suh, Chang Hee ^f   Chung, Won Tae ^g   Park, Yong Beom ^h   Choe, Jung Yoon ⁱ   Shim, Seung Cheol ^j   Lee Shin Seok, S ^k   Han, Bok Ghee ^l   Olsen, Nancy J ^m   Karp, David R ⁿ   Moser, Kathy ^a   Pons Estel, Bernardo A ^o   Wakeland, Edward K ^c   James, Judith A ^a   Harley, John B ^b   Bae, Sang Cheol ^d   Gaffney, Patrick M ^a   Alarcón Riquelme, Marta ^a   Acevedo, Eduardo ^q   La Torre, Ignacio García De ^r   Maradiaga Ceceña, Marco A ^s   Cardiel, Mario H ^t   Esquivel Valerio, Jorge A ^u   Rodriguez Amado, Jacqueline ^u   Moctezuma, José Francisco ^v   Miranda, Pedro ^w   Perandones, Carlos ^x   Castel, Cecilia ^y   Laborde, Hugo A ^z   Alba, Paula ^aa   Musuruana, Jorge ^ab   Goecke, Annelise ^ac   Foster, Carola ^ad   Orozco, Lorena ^ae   Baca, Vicente ^af   Looger, Loren L ^p   Nath, Swapan K ^a   more..

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d Hanyang University Hospital for Rheumatic Diseases   (South Korea)

^e Kyungpook National University Hospital   (South Korea)

^f Ajou University Medical Center   (South Korea)

^g Dong A University College of Medicine   (South Korea)

^h Yonsei University College of Medicine   (South Korea)

ⁱ Catholic University of Daegu   (South Korea)

^j Chungnam National University College of Medicine   (South Korea)

^k Chonnam National University Medical School   (South Korea)

^l Korea National Institute of Health   (South Korea)

^m PENN STATE COLLEGE OF MEDICINE   (United States)

ⁿ UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^o Sanatorio Parque   (Argentina)

^p HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^q HOSPITAL NACIONAL GUILLERMO ALMENARA IRIGOYEN   (Peru)

^r HOSPITAL GENERAL DE OCCIDENTE   (Mexico)

^s Hospital General de Culiacan   (Mexico)

^t HOSPITAL GENERAL DR MIGUEL SILVA   (Mexico)

^u HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^v HOSPITAL GENERAL DE MÉXICO   (Mexico)

^w HOSPITAL SAN JUAN DE DIOS   (Chile)

^x CEMIC   (Argentina)

^y Hospital Central Mendoza   (Argentina)

^z HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^aa HOSPITAL PRIVADO   (Argentina)

^ab Hospital José Bernardo Iturraspe   (Argentina)

^ac HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^ad HOSPITAL DEL SALVADOR   (Chile)

^ae INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

^af INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICANS; ASIAN AMERICANS; COMPUTATIONAL BIOLOGY; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION STUDIES; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HAPLOTYPES; HISPANIC AMERICANS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MODELS, MOLECULAR; NADPH OXIDASE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84894384556     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt532     Document Type: Article

References (99)

1. Lawrence, R.C., Helmick, C.G., Arnett, F.C., Deyo, R.A., Felson, D.T., Giannini, E.H., Heyse, S.P., Hirsch, R., Hochberg, M.C., Hunder, G.G. et al. (1998) Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum., 41, 778-799.
2. Cervera, R., Khamashta, M.A., Font, J., Sebastiani, G.D., Gil, A., Lavilla, P., Mejia, J.C., Aydintug, A.O., Chwalinska-Sadowska, H., de Ramon, E. et al. (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore), 82, 299-308.
3. Duffy, K.N., Duffy, C.M. and Gladman, D.D. (1991) Infection and disease activity in systemic lupus erythematosus: a review of hospitalized patients. J. Rheumatol., 18, 1180-1184.
4. Souza, D.C., Santo, A.H. and Sato, E.I. (2012) Mortality profile related to systemic lupus erythematosus: a multiple cause-of-death analysis. J. Rheumatol., 39, 496-503.
5. Alarcon, G.S., McGwin, G. Jr., Bastian, H.M., Roseman, J., Lisse, J., Fessler, B.J., Friedman, A.W. and Reveille, J.D. (2001) Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum., 45, 191-202.
6. Goldblatt, F., Chambers, S., Rahman, A. and Isenberg, D.A. (2009) Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality. Lupus, 18, 682-689.
7. Noel, V., Lortholary, O., Casassus, P., Cohen, P., Genereau, T., Andre, M.H., Mouthon, L. and Guillevin, L. (2001) Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann. Rheum. Dis., 60, 1141-1144.
8. Cervera, R., Khamashta, M.A., Shoenfeld, Y., Camps, M.T., Jacobsen, S., Kiss, E., Zeher, M.M., Tincani, A., Kontopoulou-Griva, I., Galeazzi, M. et al. (2008) Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicenter prospective study of 1,000 patients. Ann. Rheum. Dis., 68, 1428-1432.
9. Souza, D.C., Santo, A.H. and Sato, E.I. (2010) Trends in systemic lupus erythematosus mortality rates in the state of Sao Paulo, Brazil from 1985 to 2004. Clin. Exp. Rheumatol., 28, 519-524.
10. Kundu, S., Ghosh, P., Datta, S., Ghosh, A., Chattopadhyay, S. and Chatterjee, M. (2012) Oxidative stress as a potential biomarker for determining disease activity in patients with rheumatoid arthritis. Free Radic. Res., 46, 1482-1489.
11. Wang, G., Li, H. and Firoze Khan, M. (2012) Differential oxidative modification of proteins in MRL+/+ and MRL/lpr mice: increased formation of lipid peroxidation-derived aldehyde-protein adducts may contribute to accelerated onset of autoimmune response. Free Radic. Res., 46, 1472-1481.
12. Winyard, P.G., Ryan, B., Eggleton, P., Nissim, A., Taylor, E., Lo Faro, M.L., Burkholz, T., Szabo-Taylor, K.E., Fox, B., Viner, N. et al. (2011) Measurement and meaning of markers of reactive species of oxygen, nitrogen and sulfur in healthy human subjects and patients with inflammatory joint disease. Biochem. Soc. Trans., 39, 1226-1232.
13. Liu, Q., Cheng, L.I., Yi, L., Zhu, N., Wood, A., Changpriroa, C.M., Ward, J.M. and Jackson, S.H. (2009) P47phox deficiency induces macrophage dysfunction resulting in progressive crystalline macrophage pneumonia. Am. J. Pathol., 174, 153-163.
14. Yamauchi, A., Kim, C., Li, S., Marchal, C.C., Towe, J., Atkinson, S.J. and Dinauer, M.C. (2004) Rac2-deficient murine macrophages have selective defects in superoxide production and phagocytosis of opsonized particles. J. Immunol., 173, 5971-5979.
15. Palmby, T.R., Abe, K., Karnoub, A.E. and Der, C.J. (2004) Vav transformation requires activation of multiple GTPases and regulation of gene expression. Mol. Cancer Res., 2, 702-711.
16. Gateva, V., Sandling, J.K., Hom, G., Taylor, K.E., Chung, S.A., Sun, X., Ortmann, W., Kosoy, R., Ferreira, R.C., Nordmark, G. et al. (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet., Nov, 1228-1233.
17. Cunninghame Graham, D.S., Morris, D.L., Bhangale, T.R., Criswell, L.A., Syvanen, A.C., Ronnblom, L., Behrens, T.W., Graham, R.R. and Vyse, T.J. (2011) Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet., 7, e1002341.
18. Jacob, C.O., Eisenstein, M., Dinauer, M.C., Ming, W., Liu, Q., John, S., Quismorio, F.P. Jr., Reiff, A., Myones, B.L., Kaufman, K.M. et al. (2012) Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase. Proc. Natl Acad. Sci. USA, 109, E59-E67.
19. Yu, B., Chen, Y., Wu, Q., Li, P., Shao, Y., Zhang, J., Zhong, Q., Peng, X., Yang, H., Hu, X. et al. (2011) The association between single-nucleotide polymorphisms of NCF2 and systemic lupus erythematosus in Chinese mainland population. Clin. Rheumatol., 30, 521-527.
20. Deng, Y. and Tsao, B.P. (2010) Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat. Rev. Rheumatol., 6, 683-692.
21. Harley, I.T., Kaufman, K.M., Langefeld, C.D., Harley, J.B. and Kelly, J.A. (2009) Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies. Nat. Rev. Genet., 10, 285-290.
22. Petri, M., Perez-Gutthann, S., Longenecker, J.C. and Hochberg, M. (1991) Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am. J. Med., 91, 345-353.
23. Reveille, J.D., Moulds, J.M., Ahn, C., Friedman, A.W., Baethge, B., Roseman, J., Straaton, K.V. and Alarcon, G.S. (1998) Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum., 41, 1161-1172.
24. Fernandez, M., Alarcon, G.S., Calvo-Alen, J., Andrade, R., McGwin, G. Jr., Vila, L.M., Reveille, J.D. and Group, L.S. (2007)Amultiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum., 57, 576-584.
25. Manson, J.J. and Rahman, A. (2006) Systemic lupus erythematosus. Orphanet J. Rare Dis., 1, 6.
26. Hochberg, M.C. (1987) The application of genetic epidemiology to systemic lupus erythematosus. J. Rheumatol., 14, 867-869.
27. Tan, E.M., Cohen, A.S., Fries, J.F., Masi, A.T., McShane, D.J., Rothfield, N.F., Schaller, J.G., Talal, N. and Winchester, R.J. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum., 25, 1271-1277.
28. Cortes, A. and Brown, M.A. (2011) Promise and pitfalls of the Immunochip. Arthritis Res. Ther., 13, 101.
29. Mailman, M.D., Feolo, M., Jin, Y., Kimura, M., Tryka, K., Bagoutdinov, R., Hao, L., Kiang, A., Paschall, J., Phan, L. et al. (2007) The NCBI dbGaP database of genotypes and phenotypes. Nat. Genet., 39, 1181-1186.
30. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly, M.J. et al. (2007)PLINK:a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
31. Liu, E.Y., Li, M., Wang, W. and Li, Y. (2013) MaCH-admix: genotype imputation for admixed populations. Genet. Epidemiol., 37, 25-37.
32. Nyholt, D.R. (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am. J. Hum. Genet., 74, 765-769.
33. Li, J. and Ji, L. (2005) Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity (Edinb), 95, 221-227.
34. Alexander, D.H., Novembre, J. and Lange, K. (2009) Fast model-based estimation of ancestry in unrelated individuals. Genome Res., 19, 1655-1664.
35. Yang, J., Lee, S.H., Goddard, M.E. and Visscher, P.M. (2011) GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet., 88, 76-82.
36. Millstein, J., Conti, D.V., Gilliland, F.D. and Gauderman, W.J. (2006) A testing framework for identifying susceptibility genes in the presence of epistasis. Am. J. Hum. Genet., 78, 15-27.
37. Yang, T.P., Beazley, C., Montgomery, S.B., Dimas, A.S., Gutierrez-Arcelus, M., Stranger, B.E., Deloukas, P. and Dermitzakis, E.T. (2010) Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies. Bioinformatics, 26, 2474-2476.
38. Stranger, B.E., Montgomery, S.B., Dimas, A.S., Parts, L., Stegle, O., Ingle, C.E., Sekowska, M., Smith, G.D., Evans, D., Gutierrez-Arcelus, M. et al. (2012) Patterns of cis regulatory variation in diverse human populations. PLoS Genet., 8, e1002639.
39. Moffatt, M.F., Kabesch, M., Liang, L., Dixon, A.L., Strachan, D., Heath, S., Depner, M., von Berg, A., Bufe, A., Rietschel, E. et al. (2007) Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature, 448, 470-473.
40. Dixon, A.L., Liang, L., Moffatt, M.F., Chen, W., Heath, S., Wong, K.C., Taylor, J., Burnett, E., Gut, I., Farrall, M. et al. (2007) A genome-wide association study of global gene expression. Nat. Genet., 39, 1202-1207.
41. Unterholzner, L. and Izaurralde, E. (2004) SMG7 Acts as a molecular link between mRNA surveillance and mRNA decay. Mol. Cell, 16, 587-596.
42. Bachmann, M.P., Bartsch, H., Gross, J.K., Maier, S.M., Gross, T.F., Workman, J.L., James, J.A., Farris, A.D., Jung, B., Franke, C. et al. (2006) Autoimmunity as a result of escape from RNA surveillance. J. Immunol., 177, 1698-1707.
43. Zhao, J., Sakurai, D., Deng, Y., Sestak, A.L., Langefeld, C.D., Kaufman, K.M. and Kelly, J.A. (2011) In American College of Rheumatology. Arthritis Rheum., Chicago, Illinois, Vol. 63 Suppl 10, pp. 639.
44. Wilson, M.I., Gill, D.J., Perisic, O., Quinn, M.T. and Williams, R.L. (2003) PB1 domain-mediated heterodimerization inNADPHoxidase and signaling complexes of atypical protein kinaseCwith Par6 and p62. Mol. Cell, 12, 39-50.
45. Yanagisawa, H., Nagasawa, T., Kuramochi, S., Abe, T., Ikawa, Y. and Todokoro, K. (1991) Constitutive expression of exogenous c-myb gene causes maturation block in monocyte-macrophage differentiation. Biochim. Biophys. Acta, 1088, 380-384.
46. Maehara, Y., Miyano, K. and Sumimoto, H. (2009) Role for the first SH3 domain of p67phox in activation of superoxide-producing NADPH oxidases. Biochem. Biophys. Res. Commun., 379, 589-593.
47. Ming, W., Li, S., Billadeau, D.D., Quilliam, L.A. and Dinauer, M.C. (2007) The Rac effector p67phox regulates phagocyte NADPH oxidase by stimulating Vav1 guanine nucleotide exchange activity. Mol. Cell Biol, 27, 312-323.
48. Song, E., Jaishankar, G.B., Saleh, H., Jithpratuck, W., Sahni, R. and Krishnaswamy, G. (2011) Chronic granulomatous disease: a review of the infectious and inflammatory complications. Clin. Mol. Allergy, 9, 10.
49. Roesler, J., Segerer, F., Morbach, H., Kleinert, S., Thieme, S., Rosen-Wolff, A. and Liese, J.G. (2012) P67-phox (NCF2) lacking exons 11 and 12 is functionally active and leads to an extremely late diagnosis of chronic granulomatous disease (CGD). PLoS One, 7, e34296.
50. Grizot, S., Fieschi, F., Dagher, M.C. and Pebay-Peyroula, E. (2001) The active N-terminal region of p67phox. Structure at 1.8 A resolution and biochemical characterizations of the A128 V mutant implicated in chronic granulomatous disease. J. Biol. Chem., 276, 21627-21631.
51. Mizuki, K., Takeya, R., Kuribayashi, F., Nobuhisa, I., Kohda, D., Nunoi, H., Takeshige, K. and Sumimoto, H. (2005) A region C-terminal to the proline-rich core of p47phox regulates activation of the phagocyte NADPH oxidase by interacting with the C-terminal SH3 domain of p67phox. Arch. Biochem. Biophys., 444, 185-194.
52. de Boer, M., Hartl, D., Wintergerst, U., Belohradsky, B.H. and Roos, D. (2005) A donor splice site mutation in intron 1 of CYBA, leading to chronic granulomatous disease. Blood Cells Mol. Dis., 35, 365-369.
53. Jirapongsananuruk, O., Noack, D., Boonchoo, S., Thepthai, C., Chokephaibulkit, K., Visitsunthorn, N., Vichyanond, P., Luangwedchakarn, V., Likasitwattanakul, S. and Piboonpocanun, S. (2007)Anovel mutation of the CYBB gene resulting in severe form of X-linked chronic granulomatous disease. Asian Pac. J. Allergy Immunol., 25, 249-252.
54. Lewis, E.M., Singla, M., Sergeant, S., Koty, P.P. and McPhail, L.C. (2008) X-linked chronic granulomatous disease secondary to skewed X chromosome inactivation in a female with a novel CYBB mutation and late presentation. Clin. Immunol., 129, 372-380.
55. Teimourian, S., Zomorodian, E., Badalzadeh, M., Pouya, A., Kannengiesser, C., Mansouri, D., Cheraghi, T. and Parvaneh, N. (2008) Characterization of six novel mutations in CYBA: the gene causing autosomal recessive chronic granulomatous disease. British J. Haematol., 141, 848-851.
56. El Kares, R., Barbouche, M.R., Elloumi-Zghal, H., Bejaoui, M., Chemli, J., Mellouli, F., Tebib, N., Abdelmoula, M.S., Boukthir, S., Fitouri, Z. et al. (2006) Genetic and mutational heterogeneity of autosomal recessive chronic granulomatous disease in Tunisia. J. Hum. Genet., 51, 887-895.
57. van den Berg, J.M., van Koppen, E., Ahlin, A., Belohradsky, B.H., Bernatowska, E., Corbeel, L., Espanol, T., Fischer, A., Kurenko-Deptuch, M., Mouy, R. et al. (2009) Chronic granulomatous disease: the European experience. PLoS One, 4, e5234.
58. Koker, M.Y., van Leeuwen, K., de Boer, M., Celmeli, F., Metin, A., Ozgur, T.T., Tezcan, I., Sanal, O. and Roos, D. (2009) Six different CYBA mutations including three novel mutations in ten families from Turkey, resulting in autosomal recessive chronic granulomatous disease. Eur. J. Clin. Invest., 39, 311-319.
59. Gentsch, M., Kaczmarczyk, A., van Leeuwen, K., de Boer, M., Kaus-Drobek, M., Dagher, M.C., Kaiser, P., Arkwright, P.D., Gahr, M., Rosen-Wolff, A. et al. (2010) Alu-repeat-induced deletions within theNCF2 gene causing p67-phox-deficient chronic granulomatous disease (CGD). Hum. Mutat., 31, 151-158.
60. Roos, D., Kuhns, D.B., Maddalena, A., Roesler, J., Lopez, J.A., Ariga, T., Avcin, T., de Boer, M., Bustamante, J., Condino-Neto, A. et al. (2010) Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol. Dis., 45, 246-265.
61. Teimourian, S., de Boer, M. and Roos, D. (2010) Molecular basis of autosomal recessive chronic granulomatous disease in Iran. J. Clin. Immunol., 30, 587-592.
62. Roos, D., Kuhns, D.B., Maddalena, A., Bustamante, J., Kannengiesser, C., de Boer, M., van Leeuwen, K., Koker, M.Y., Wolach, B., Roesler, J. et al. (2010) Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update). Blood Cells Mol. Dis., 44, 291-299.
63. Noack, D., Rae, J., Cross, A.R., Munoz, J., Salmen, S., Mendoza, J.A., Rossi, N., Curnutte, J.T. and Heyworth, P.G. (1999) Autosomal recessive chronic granulomatous disease caused by novel mutations in NCF-2, the gene encoding the p67-phox component of phagocyte NADPH oxidase. Hum. Genet., 105, 460-467.
64. Patino, P.J., Rae, J., Noack, D., Erickson, R., Ding, J., de Olarte, D.G. and Curnutte, J.T. (1999) Molecular characterization of autosomal recessive chronic granulomatous disease caused by a defect of the nicotinamide adenine dinucleotide phosphate (reduced form) oxidase component p67-phox. Blood, 94, 2505-2514.
65. Lapouge, K., Smith, S.J., Walker, P.A., Gamblin, S.J., Smerdon, S.J. and Rittinger, K. (2000) Structure of the TPR domain of p67phox in complex with Rac. GTP. Mol. Cell, 6, 899-907.
66. Muise, A.M., Xu, W., Guo, C.H., Walters, T.D., Wolters, V.M., Fattouh, R., Lam, G.Y., Hu, P., Murchie, R., Sherlock, M. et al. (2011) NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2. Gut., 61, 1028-1035.
67. Roberts, R.L., Hollis-Moffatt, J.E., Gearry, R.B., Kennedy, M.A., Barclay, M.L. and Merriman, T.R. (2008) Confirmation of association of IRGM and NCF4 with ileal Crohn's disease in a population-based cohort. Genes Immun., 9, 561-565.
68. Somasundaram, R., Deuring, J.J., van der Woude, C.J., Peppelenbosch, M.P. and Fuhler, G.M. (2012) Linking risk conferring mutations in NCF4 to functional consequences in Crohn's disease. Gut, 61, 1097; author reply 1097-1098.
69. Olsson, L.M., Lindqvist, A.K., Kallberg, H., Padyukov, L., Burkhardt, H., Alfredsson, L., Klareskog, L. and Holmdahl, R. (2007)Acase-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity. Arthritis Res. Ther., 9, R98.
70. Hunt, K.A., Mistry, V., Bockett, N.A., Ahmad, T., Ban, M., Barker, J.N., Barrett, J.C., Blackburn, H., Brand, O., Burren, O. et al. (2013) Negligible impact of rare autoimmune-locus coding-region variants on missing heritability. Nature, 498, 232-235.
71. Babior, B.M. (2004) NADPH oxidase. Curr. Opin. Immunol., 16, 42-47.
72. Bylund, J., Brown, K.L., Movitz, C., Dahlgren, C. and Karlsson, A. (2010) Intracellular generation of superoxide by the phagocyte NADPH oxidase: how, where, and what for? Free Radic. Biol. Med., 49, 1834-1845.
73. Nauseef, W.M. (2008) Biological roles for the NOX family NADPH oxidases. J. Biol. Chem., 283, 16961-16965.
74. Bae, Y.S., Oh, H., Rhee, S.G. and Yoo, Y.D. (2011) Regulation of reactive oxygen species generation in cell signaling. Mol. Cells, 32, 491-509.
75. de Oliveira-Junior, E.B., Bustamante, J., Newburger, P.E. and Condino-Neto, A. (2011) The human NADPH oxidase: primary and secondary defects impairing the respiratory burst function and the microbicidal ability of phagocytes. Scand. J. Immunol., 73, 420-427.
76. Ferro, E., Goitre, L., Retta, S.F. and Trabalzini, L. (2012) The interplay between ROS and Ras GTPases: physiological and pathological implications. J. Signal. Transduct., 2012, 365769.
77. Bhogal, R.H., Weston, C.J., Curbishley, S.M., Adams, D.H. and Afford, S.C. (2012) Autophagy: a cyto-protective mechanism which prevents primary human hepatocyte apoptosis during oxidative stress. Autophagy, 8, 545-558.
78. Lande, R., Ganguly, D., Facchinetti, V., Frasca, L., Conrad, C., Gregorio, J., Meller, S., Chamilos, G., Sebasigari, R., Riccieri, V. et al. (2011) Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med., 3, 73ra19.
79. Kirchner, T., Moller, S., Klinger, M., Solbach, W., Laskay, T. and Behnen, M. (2012) The impact of various reactive oxygen species on the formation of neutrophil extracellular traps. Mediators Inflamm., 2012, 849136.
80. Campbell, A.M., Kashgarian, M. and Shlomchik, M.J. (2012) NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus. Sci. Transl. Med., 4, 157ra141.
81. Elkon, K.B. and Santer, D.M. (2012) Complement, interferon and lupus. Curr. Opin. Immunol., 24, 665-670.
82. Bouts, Y.M., Wolthuis, D.F., Dirkx, M.F., Pieterse, E., Simons, E.M., van Boekel, A.M., Dieker, J.W. and van der Vlag, J. (2012) Apoptosis and NET formation in the pathogenesis of SLE. Autoimmunity, 45, 597-601.
83. Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D.S., Weinrauch, Y. and Zychlinsky, A. (2004) Neutrophil extracellular traps kill bacteria. Science, 303, 1532-1535.
84. Arazna, M., Pruchniak, M.P., Zycinska, K. and Demkow, U. (2013) Neutrophil extracellular trap in human diseases. Adv. Exp. Med. Biol., 756, 1-8.
85. Leffler, J., Martin, M., Gullstrand, B., Tyden, H., Lood, C., Truedsson, L., Bengtsson, A.A. and Blom, A.M. (2012) Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J. Immunol., 188, 3522-3531.
86. Rasmussen, A., Sevier, S., Kelly, J.A., Glenn, S.B., Aberle, T., Cooney, C.M., Grether, A., James, E., Ning, J., Tesiram, J. et al. (2011) The Lupus Family Registry and Repository. Rheumatology (Oxford), 50, 47-59.
87. Hochberg, M.C. (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum., 40, 1725.
88. Adrianto, I., Wen, F., Templeton, A., Wiley, G., King, J.B., Lessard, C.J., Bates, J.S., Hu, Y., Kelly, J.A., Kaufman, K.M. et al. (2011) Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat. Genet., 43, 253-258.
89. Liu, J.Z., Hov, J.R., Folseraas, T., Ellinghaus, E., Rushbrook, S.M., Doncheva, N.T., Andreassen, O.A., Weersma, R.K., Weismuller, T.J., Eksteen, B. et al. (2013) Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat. Genet., 45, 670-675.
90. Eyre, S., Bowes, J., Diogo, D., Lee, A., Barton, A., Martin, P., Zhernakova, A., Stahl, E., Viatte, S., McAllister, K. et al. (2012) High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat. Genet., 44, 1336-1340.
91. Patterson, N., Hattangadi, N., Lane, B., Lohmueller, K.E., Hafler, D.A., Oksenberg, J.R., Hauser, S.L., Smith, M.W., O'Brien, S.J., Altshuler, D. et al. (2004) Methods for high-density admixture mapping of disease genes. Am. J. Hum. Genet., 74, 979-1000.
92. Price, A.L., Patterson, N.J., Plenge, R.M., Weinblatt, M.E., Shadick, N.A. and Reich, D. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet., 38, 904-909.
93. Alexander, D.H., Novembre, J. and Lange, K. (2009) Fast model-based estimation of ancestry in unrelated individuals. Genome Res., 19, 1655-1664.
94. Purcell, S., Daly, M.J. and Sham, P.C. (2007) WHAP: haplotype-based association analysis. Bioinformatics, 23, 255-256.
95. Macgregor, S. and Khan, I.A. (2006) GAIA: an easy-to-use web-based application for interaction analysis of case-control data. BMC Med. Genet., 7, 34.
96. Chen, G.B., Xu, Y., Xu, H.M., Li, M.D., Zhu, J. and Lou, X.Y. (2011) Practical and theoretical considerations in study design for detecting gene-gene interactions using MDR and GMDR approaches. PLoS One, 6, e16981.
97. Lou, X.Y., Chen, G.B., Yan, L., Ma, J.Z., Zhu, J., Elston, R.C. and Li, M.D. (2007) A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am. J. Hum. Genet., 80, 1125-1137.
98. Ritchie, M.D., Hahn, L.W., Roodi, N., Bailey, L.R., Dupont, W.D., Parl, F.F. and Moore, J.H. (2001) Multifactor-dimensionality reduction reveals high-order interactionsamongestrogen-metabolism genes in sporadic breast cancer. Am. J. Hum. Genet., 69, 138-147.
99. Klan, N. and Steinhilber, D. (2003) Transient transfection of the human myeloid cell line Mono Mac 6 using electroporation. Biotechniques, 34, 142-147.